Advertisement
U.S. markets closed

Priveterra Acquisition Corp. II (PMGM)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
11.030.00 (0.00%)
At close: 11:34AM EST
Full screen
Loading interactive chart...
  • GlobeNewswire

    AEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline Update

    Common stock and warrants of combined company will be listed on the New York Stock Exchange American under the symbols AEON and AEON WS, respectively Phase 2 topline data with ABP-450 for the preventive treatment of episodic migraine is anticipated to readout this fall $50 million financing provides sufficient cash runway to fund operations beyond the anticipated Phase 2 data announcement this fall IRVINE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (

  • Business Wire

    Priveterra Acquisition Corp. Announces Completion of Business Combination with AEON Biopharma, Inc.

    FORT LAUDERDALE, Fla., July 21, 2023--Priveterra Acquisition Corp. (Nasdaq: PMGM) ("Priveterra"), a special purpose acquisition company led by Chairman & CEO, Robert Palmisano, along with President, Vikram Malik, and COO and CFO, Oleg Grodnensky, today announced the successful completion of its business combination (the "Business Combination") with AEON Biopharma, Inc. ("AEON"), a Phase 3 stage-ready biopharmaceutical company developing a proprietary neurotoxin with initial focus on preventive t

  • Business Wire

    Priveterra Acquisition Corp. Announces Authorization to List on NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.

    FORT LAUDERDALE, Fla., July 17, 2023--Priveterra Acquisition Corp. (Nasdaq: PMGM) ("Priveterra" and, after the consummation of its pending business combination (the "Business Combination") and following its name change to AEON Biopharma, Inc., "New AEON") today announced that NYSE Regulation, on July 13, 2023, authorized New AEON common stock ("New AEON Common Stock") and New AEON warrants to be listed on NYSE American LLC ("NYSE") upon the Business Combination with AEON Biopharma, Inc., ("AEON"